4.7 Article

M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia

Related references

Note: Only part of the references are listed.
Article Oncology

EMA vs EMACO in the treatment of gestational trophoblastic neoplasia

Nida Jareemit et al.

GYNECOLOGIC ONCOLOGY (2020)

Article Obstetrics & Gynecology

Update on the diagnosis and management of gestational trophoblastic disease

Hextan Y. S. Ngan et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)

Article Oncology

Distance from treating hospital and colorectal cancer survivors' quality of life: a gendered analysis

Audrey Alforque Thomas et al.

SUPPORTIVE CARE IN CANCER (2015)

Article Obstetrics & Gynecology

Gestational trophoblastic neoplasia - Treatment outcomes

Anna V. Hoekstra et al.

OBSTETRICS AND GYNECOLOGY (2008)

Article Medicine, General & Internal

Choriocarcinoma and partial hydatidiform moles

MJ Seckl et al.

LANCET (2000)